Figure 4:

Box plots show mouse fluorescence imaging studies of ^99mTc-labeled Cy7 tilmanocept demonstrated receptor binding to SLNs. Cy7 tilmanocept SLN uptake rate constant in the low-dose group (1.36 hours⁻¹ ± 0.66) was significantly (P = .005) greater than that in the high-dose group (0.33 hours⁻¹ ± 0.34). Uptake peak as measured by peak scaled fluorescence intensity was significantly (P = .018) higher in the low-dose group (220 counts · sec⁻¹ · μW⁻¹ ± 140) than in the high-dose group (55 counts · sec⁻¹ · μW⁻¹ ± 42).